Privium Fund Management B.V. has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The filing lists 58 separate positions held by the firm, with the total value of the portfolio not explicitly stated in the provided text.
The largest position disclosed in the filing is in OpenDoor Technologies Inc., where the firm holds 5,140,904 shares. Other notable positions include Tesla Inc., with 22,500,000 shares; SpaceX Exploration Tech Corp., with 25,000,000 shares; and Palantir Technologies Inc. Class A, with 200,000 shares.
The portfolio is heavily weighted toward the healthcare and biotechnology sectors. Key holdings in this sector include ProQR Therapeutics N.V., with 5,467,149 shares; Ionis Pharmaceuticals Inc., with 349,003 shares; and Voyager Therapeutics Inc., with 120,000 shares. Other biotechnology companies listed in the filing include Aryn Sands, Advanced Micro Devices Inc., Alnylam Pharmaceuticals Inc., and Ambev SA Sponsored ADR.
The filing also includes positions in various other industries, such as consumer discretionary, energy, and technology. Notable holdings in these sectors include Shopify Inc. Class A, with 305,000 shares; Sprott Funds Trust Uranium Miner ETF, with 8,178 shares; and Expand Energy Corporation, with 3,046 shares.
Privium Fund Management B.V. is headquartered at Gustav Mahlerplein 3 in Amsterdam, P7 1082 MS, and the filing was signed by Aryn Sands, an agent, on November 2, 2026.
